Biomarkers

TECHNOLOGY: Plasma markers

Serum levels of IL-6 and MCP-1 could help predict the risk of neurologic adverse

Read the full 163 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE